Nicholas Haft
CIK 1850404 · last filed 2023-06-09
Nicholas Haft is a corporate insider who has filed 4 SEC Form 4 insider transactions across 1 company since 2021. The most recent filing, for FNCH, was dated Jun 9, 2023. Across all open-market trades the lifetime net is +$15.6M, making them a net buyer over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
1
4
$15.65M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Finch Therapeutics Group, Inc. (FNCH) Delisted | Director | 4,056,907 | $7.30 | $29.62M | $15.65M | 4 | 2023-06-09 |
Recent Filings
4 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-06-09 | Finch Therapeutics Group, Inc. (FNCH) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-06-15 | Finch Therapeutics Group, Inc. (FNCH) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-12-22 | Finch Therapeutics Group, Inc. (FNCH) Delisted | Buy (P) | +63,850 | $650.0K | EDGAR |
| 2021-03-25 | Finch Therapeutics Group, Inc. (FNCH) Delisted | Mixed | +3,993,057 | $15.00M | EDGAR |